Serum Institute gets approval to resume Indian trial of AstraZeneca COVID vaccine

Serum Institute of India has received Indian regulatory approval to resume local clinical trials of AstraZeneca's potential COVID-19 vaccine, a source familiar with the matter said on Wednesday.

from bdnews24.com - Home https://ift.tt/3c39xkp